Nationwide epidemiological survey of familial myelodysplastic syndromes/acute myeloid leukemia in Japan: a multicenter retrospective study

References

• Holme H, Hossain U, Kirwan M, et al. Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia. Br J Haematol. 2012;158(2):242–248.
   PubMed Web of Science ®Google Scholar
• Hahn CN, Chong C-E, Carmichael CL, et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet. 2011;43(10):1012–1017.
   PubMed Web of Science ®Google Scholar
• Harada H, Harada Y, Kimura A. Implications of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome (MDS): future molecular therapeutic directions for MDS. Curr Cancer Drug Targets. 2006;6(6):553–563.
   PubMed Web of Science ®Google Scholar
• Bejar R, Steensma DP. Recent developments in myelodysplastic syndromes. Blood. 2014;124(18):2793–2803.
   PubMed Web of Science ®Google Scholar
• Walter MJ, Shen D, Ding L, et al. Clonal architecture of secondary acute myeloid leukemia. N Engl J Med. 2012;366(12):1090–1098.
   PubMed Web of Science ®Google Scholar
• Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89(6):2079–2088.
   PubMed Web of Science ®Google Scholar
• Stone RM. How I treat patients with myelodysplastic syndromes. Blood. 2009;113(25):6296–6303.
   PubMed Web of Science ®Google Scholar
• Alessandrino EP, Della Porta MG, Bacigalupo A, et al. WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood. 2008;112(3):895–902.
   PubMed Web of Science ®Google Scholar
• Churpek JE, Lorenz R, Nedumgottil S, et al. Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes. Leuk Lymphoma. 2013;54(1):28–35.
   PubMed Web of Science ®Google Scholar
• Nickels EM, Soodalter J, Churpek JE, et al. Recognizing familial myeloid leukemia in adults. Ther Adv Hematol. 2013;4(4):254–269.
   PubMedGoogle Scholar
• Liew E, Owen C. Familial myelodysplastic syndromes: a review of the literature. Haematologica. 2011;96(10):1536–1542.
   PubMed Web of Science ®Google Scholar
• Owen C, Barnett M, Fitzgibbon J. Familial myelodysplasia and acute myeloid leukaemia – a review. Br J Haematol. 2007;140(2):123–132.
   Web of Science ®Google Scholar
• Bennett JM, Catovsky D, Daniel M, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51(2):189–199.
   PubMed Web of Science ®Google Scholar
• Swerdlow SC, Harris NL, Jaffe ES, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. France: The International Agency for Research on Cancer (IARC), World Health Organization; 2008.
   Google Scholar
• Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–2465.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Greenberg PL, Bennett JM, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 2006;108(2):419–425.
   PubMed Web of Science ®Google Scholar
• Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115(3):453–474.
   PubMed Web of Science ®Google Scholar
• Yoshimi A, Toya T, Nannya Y, et al. Spectrum of clinical and genetic features of patients with inherited platelet disorder with suspected predisposition to hematological malignancies: a nationwide survey in Japan. Ann Oncol. 2016;27(5):887–895.
   PubMed Web of Science ®Google Scholar
• Takaoka K, Kawazu M, Koya J, et al. A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination. Leukemia. 2019;33(7):1773–1782.
   PubMed Web of Science ®Google Scholar
• Ding L-W, Ikezoe T, Tan K-T, et al. Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency. Leukemia. 2017;31(1):244–245.
   PubMed Web of Science ®Google Scholar
• Montané E, Ibáñez L, Vidal X, et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica. 2008;93(4):518–523.
   PubMed Web of Science ®Google Scholar
• Goldin LR, Kristinsson SY, Liang XS, et al. Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol. 2012;30(2):179–183.
   PubMed Web of Science ®Google Scholar
• Kawabata H, Tohyama K, Matsuda A, et al. Validation of the revised International Prognostic Scoring System in patients with myelodysplastic syndrome in Japan: results from a prospective multicenter registry. Int J Hematol. 2017;106(3):375–384.
   PubMed Web of Science ®Google Scholar
• Michaud J, Wu F, Osato M, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood. 2002;99(4):1364–1372.
   PubMed Web of Science ®Google Scholar
• Song W-J, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23(2):166–175.
   PubMed Web of Science ®Google Scholar
• Smith ML, Cavenagh JD, Lister TA, et al. Mutation of CEBPA in familial acute myeloid leukemia. N Engl J Med. 2004;351(23):2403–2407.
   PubMed Web of Science ®Google Scholar
• Vulliamy T, Marrone A, Szydlo R, et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet. 2004;36(5):447–449.
   PubMed Web of Science ®Google Scholar
• West AH, Godley LA, Churpek JE. Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations. Ann NY Acad Sci. 2014;1310(1):111–118.
   PubMedGoogle Scholar
• Polprasert C, Schulze I, Sekeres MA, et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell. 2015;27(5):658–670.
   PubMed Web of Science ®Google Scholar
• Zhang MY, Churpek JE, Keel SB, et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat Genet. 2015;47(2):180–185.
   PubMed Web of Science ®Google Scholar
• Kirwan M, Walne AJ, Plagnol V, et al. Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia. Am J Hum Genet. 2012;90(5):888–892.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Przychodzen BP, Hirsch CM, et al. Germline SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes. Blood. 2017;130 (Supplement 1): 1670.
   Web of Science ®Google Scholar
• Sud A, Chattopadhyay S, Thomsen H, et al. Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. Blood. 2018;132(9):973–976.
   PubMed Web of Science ®Google Scholar
• Shah A, Andersson TML, Rachet B, et al. Survival and cure of acute myeloid leukaemia in E ngland, 1971‐2006: a population–based study. Br J Haematol. 2013;162(4):509–516.
   PubMed Web of Science ®Google Scholar